Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
it reflects the clinics expertise, safety, and patient guidance
For any investment decisions, consult a reputable financial advisor
Home-based physical activity and diet intervention to improve physical function in advanced liver disease: a randomized pilot trial
And still they come over troubled waters: can Asias third-generation EGFR tyrosine kinase inhibitors (furmonertinib, aumolertinib, rezivertinib, limertinib, befotertinib, SH-1028, and lazertinib) affect global treatment of EGFR + NSCLC
Engineered histidine-rich peptides enhance endosomal escape for antibody-targeted intracellular delivery of functional proteins
US$ 20.27
US$ 22.21
US$ 28.13
US$ 25.22
US$ 29.34
US$ 21.92
US$ 24.73
US$ 25.47
US$ 29.83
US$ 29.46
